Skip to main content

Advertisement

SpringerLink
Log in

2013 FDA drug approvals

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This article has been updated

Although the FDA's 27 new approvals are down from the 15-year high of 2012, the newcomers pack powerful commercial potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: FDA NME approvals since 1993.
Figure 2: Aggregate peak drug sales since 2004.
Figure 3

Change history

  • 07 February 2014

    The titles of David Greber and Ulrik Schulze have been updated online.

Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullard, A. 2013 FDA drug approvals. Nat Rev Drug Discov 13, 85–89 (2014). https://doi.org/10.1038/nrd4239

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4239

  • Springer Nature Limited

This article is cited by

Search

Navigation